Phase
Condition
Enuresis
Bladder Disorders
Urinary Incontinence
Treatment
Fetoscopes
Fetal Cystoscopy
Clinical Study ID
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Pregnant women
Singleton pregnancy
Maternal age ≥ 18 years
Male fetus with LUTO, dilated bladder, "keyhole sign" and bilateral hydronephrosis
Oligohydramnios or Anhydramnios
Favorable urine analysis defined as urinary sodium is < 100 milliequivalents perliter (mEq/L), chloride < 90 mEq/L, and osmolality < 200 milliosmoles per kilogram (mOsm/kg) after 20 weeks and in the absence of previous in utero intervention forthe disease (vesicoamniotic shunt placement or fetal cystoscopy).
Absence of chromosomal abnormalities and associated anomalies
Gestational age at the time of the procedure will be between 16 0/7 weeks and 25 6/7weeks
Normal karyotype by invasive testing (amniocentesis or Chorionic Villus Sampling (CVS)). Patients declining invasive testing will be excluded.
Family have considered and declined the option of termination of the pregnancy atless than 24 weeks.
Family meets psychosocial criteria, including sufficient social support and abilityto understand requirements of the study.
Parents or guardian are willing to provide signed informed consent.
Exclusion
Exclusion Criteria:
Fetal anomaly unrelated to LUTO
Congenital cardiac anomaly
Female fetus
Increased risk for preterm labor including short cervical length (<1.5 cm), historyof incompetent cervix with or without cerclage, and previous preterm birth
Placental abnormalities (previa, abruption, accreta) known at time of enrollment
Contraindications to surgery including previous hysterotomy in active uterinesegment
Technical limitations precluding fetoscopic surgery, such as uterine fibroids, fetalmembrane separation, uterine anomalies incompatible with fetoscopy
Maternal-fetal Rh isoimmunization, Kell sensitization or neonatal alloimmunethrombocytopenia affecting the current pregnancy
Maternal HIV, Hepatitis-B, Hepatitis-C status positive because of the increased riskof transmission to the fetus during maternal-fetal surgery. If the patient's HIV orHepatitis status is unknown, the patient must be tested and found to have negativeresults before enrollment
Maternal medical condition that is a contraindication to surgery or anesthesia
Patient does not have health insurance to cover routine clinical care includingprenatal care, prenatal ultrasound, amniocentesis, tocolysis, admission, delivery,and fetal vesico-amniotic shunting. The exception will be fetal cystoscopy which isconsidered an experimental procedure.
Inability to comply with travel and follow-up requirements of the trial
Participation in another intervention study that influences maternal and fetalmorbidity and mortality or participation in this trial in a previous pregnancy
Patients declining invasive testing
Family does not meet psychosocial criteria including insufficient
Study Design
Connect with a study center
University of Miami
Miami, Florida 33136
United StatesSite Not Available
University of Miami
Miami 4164138, Florida 4155751 33136
United StatesActive - Recruiting
Mayo Clinic
Rochester, Minnesota 55905
United StatesSite Not Available
Mayo Clinic
Rochester 5043473, Minnesota 5037779 55905
United StatesTerminated

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.